RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Growth Disorders - Pipeline Review, H2 2011
Sep 2011 - 66 pages - $500
Growth Disorders - Pipeline Review, Q1 2011
Feb 2011 - 36 pages - $500
Metabolic and Endocrinology Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
Sleep Disorders - Pipeline Review, Q3 2011
Jul 2011 - 136 pages - $500
Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q1 2011
Mar 2011 - 47 pages - $500
Epidemiology: Autism Spectrum Disorders - Increasing recognition drives growth of treatable population
Feb 2011 - 42 pages - $5,700
Lixte Biotechnology Holdings, Inc. (LIXT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 17 pages - $250
Panic Disorders - Pipeline Review, Q2 2011
May 2011 - 34 pages - $500
Lixte Biotechnology Holdings, Inc. (LIXT) - Strategic SWOT Analysis Review
May 2011 - 20 pages - $125
More Related Market Research Reports >>>

Your selection

Industry sector
Biotechnology del
Research supplies del
Therapeutic target
Endocrinology del
Growth disorders del
Year
2011 del

Browse By

Therapeutic target
Growth hormone replacement (other)
Growth hormone replacement (pediatric)

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us